Aye - I tend to agree unless there really is excess demand for the IPO and the NDQ price rapidly appreciates... Otherwise, our real inflection points are news and we have plenty of that due in next QTR; Psych #2, 675A trial starting, OSA results, TBI pre-clin etc etc
I will caveat this by saying AHI is booooooring stuff. IHL has shrooms! Just jokes (but not really)
IHL Price at posting:
56.5¢ Sentiment: Buy Disclosure: Held